Last update 01 Nov 2024
Santen Pharmaceutical (China) Co. Ltd.
Last update 01 Nov 2024
Overview
Tags
Eye Diseases
Immune System Diseases
Skin and Musculoskeletal Diseases
Small molecule drug
Synthetic peptide
Chemical drugs
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
0.1%STN1011403滴眼液治疗过敏性结膜炎的多中心随机评价者盲态阳性对照试验
[Translation] A multicenter randomized evaluator-blind positive controlled trial of 0.1% STN1011403 eye drops in the treatment of allergic conjunctivitis
以健康中国成年人为对象评价STN1013400 滴眼液的安全性及药代动力学的临床试验
[Translation] A clinical trial evaluating the safety and pharmacokinetics of STN1013400 eye drops in healthy Chinese adults
一项在儿童近视受试者中评价DE-127滴眼液（不同浓度）的安全性和有效性的随机、双盲、安慰剂对照、平行组、多中心研究
–II/III期确证性研究
[Translation] A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety and efficacy of DE-127 eye drops (different concentrations) in pediatric myopic subjects
– Phase II/III confirmatory study
100 Clinical Results associated with Santen Pharmaceutical (China) Co. Ltd.
Login to view more data
Login to view more data
Iyakuhin Iryo Kiki Regyuratori Saiensu
Manufacturing environments and facilities of sterile pharmaceutical products blow-fill-seal
Author: Hinomoto, Tsutomu
100 Deals associated with Santen Pharmaceutical (China) Co. Ltd.
Login to view more data
100 Translational Medicine associated with Santen Pharmaceutical (China) Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 07 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
1
NDA/BLA
Approved
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free